Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Merck
Citi
Covington
Federal Trade Commission
Chubb
Fuji
UBS

Generated: April 23, 2018

DrugPatentWatch Database Preview

TRICHLOREX Drug Profile

« Back to Dashboard

When do Trichlorex patents expire, and when can generic versions of Trichlorex launch?

Trichlorex is a drug marketed by Lannett and is included in two NDAs.

The generic ingredient in TRICHLOREX is trichlormethiazide. There is one drug master file entry for this compound. Additional details are available on the trichlormethiazide profile page.
Drug patent expirations by year for TRICHLOREX
Medical Subject Heading (MeSH) Categories for TRICHLOREX
Synonyms for TRICHLOREX
(+-)-6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
133-67-5
2764AH
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-dioxide, (+-)-
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-,1,1-dioxide
2h-1,2,4-benzothiadiazine-7-sulfonamide,6-chloro-3-(dichloromethyl)-3,4-dihydr
2H-1,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-dioxide
3-(dichloromethyl)-6-chloro-1,1-dioxo-2H,3H,4H-benzo[e]1,2,4-thiadiazine-7-sul fonamide
3-(Dichloromethyl)-6-chloro-7-sulfamoyl-3,2,4-benzothiadiazine 1,1-dioxide
3-(Dichloromethyl)-6-chloro-7-sulfamoyl-3,2,4-benzothiadiazine-1,1-dioxide
3-(Dichloromethyl)-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
3-(Dichloromethyl)-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
3-dichloromethyl-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1
3-Dichloromethyl-6-chloro-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
3-Dichloromethyl-6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
3-Dichloromethyl-6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine1,1-dioxide
3-Dichloromethylhydrochlorothiazide
54260-EP2269989A1
54260-EP2272832A1
54260-EP2308562A2
6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1?^{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1$l;{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide
6-Chloro-3-(dichloromethyl)-3,2,4-benzothiadiazine-7-sulfonamide1,1-dioxide
6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide1,1-dioxide
6-Chloro-3-(dichloromethyl)-3,4-dihydro-2H-1,2,4-thiadiazine-7-sulfonamide 1,1-dioxide
6-chloro-3-(dichloromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-3-(dichloromethyl)3,2,4-benzothiadiazine-1,1-dioxide
6-Chloro-3-(dichloromethyl)3,4-dihydro-7-sulfamoyl-1,2,4-benzothiadiazine-1,1-dioxide
6-Chloro-3-(dichloromethyl)3,4-dihydro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide
6-Chloro-3-[dichloromethyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide
6-Chloro-3-dichloromethyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-Dioxide
6-Chloro-3-dichloromethyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine1,1-dioxide
66946-EP2295406A1
66946-EP2298772A1
66946-EP2298776A1
66946-EP2308839A1
96782-89-7
AB00052117
AB00052117_16
AB00052117_17
AB00052117-15
AB2000205
AC1L1KMB
AC1Q6TQ0
Achletin
Achletin (TN)
Achletin;Diu-Hydrin;Triflumen
AKOS024374993
American Urologicals Brand of Trichloromethiazide
AN-43719
Anistadin
ANW-42313
API0008988
Aponorin
Aquazide
BDBM26998
BPBio1_000825
BRD-A28940325-001-05-9
BRN 0629145
BSPBio_000749
BSPBio_002926
C-44332
C07767
Carvacron
CAS-133-67-5
CCG-212834
CHEBI:9683
CHEMBL1054
Chlopolidine
Ciba 7057-Su
Cretonin
CS-2203
CTK8B3334
D00658
D0Y2IZ
DB01021
Diu-Hydrin
Diu-Hydrin (TN)
Diurazida
Diurese
Diuroral
DivK1c_000366
DSSTox_CID_3699
DSSTox_GSID_23699
DSSTox_RID_77154
DTXSID7023699
EINECS 205-118-8
Esmarin
Eurinol
Fluitran
Flurese
Flurese (VAN)
Flutra
FT-0746865
Gangesol
GTPL7314
HE021387
HE307093
HMS1570F11
HMS1921G13
HMS2090G08
HMS2092O19
HMS2097F11
HMS2235K21
HMS3371B09
HMS3655I17
HMS501C08
HSDB 3406
HY-B0235
Hydrotrichlorothiazide
I14-107329
IDI1_000366
Intromene
Isestran
Jones Brand of Trichloromethiazide
KBio1_000366
KBio2_001000
KBio2_003568
KBio2_006136
KBio3_002146
KBioGR_000833
KBioSS_001000
Kubacron
LMJSLTNSBFUCMU-UHFFFAOYSA-N
LS-40435
MCULE-5170594512
Metahydrin
Metatensin
MFCD00057315
MLS000028705
MLS001076545
MolPort-003-666-298
Nakva
Naqua
Naqua (TN)
Naquasone
NCGC00016398-01
NCGC00018302-02
NCGC00018302-03
NCGC00018302-04
NCGC00018302-07
NCGC00018302-08
NCGC00089756-02
NCGC00089756-03
NCIOpen2_007750
NINDS_000366
NSC 61560
NSC-61560
NSC-757368
NSC61560
NSC757368
Opera_ID_1588
Pharmakon1600-01500590
Prestwick_1020
Prestwick0_000825
Prestwick1_000825
Prestwick2_000825
Prestwick3_000825
Q-201860
s1667
Salurin (wadel)
SBI-0051544.P002
SC-80012
Schebitran
SCHEMBL25492
Schering Brand of Trichlormethiazide
SMR000058712
SPBio_000916
SPBio_002670
Spectrum_000520
SPECTRUM1500590
Spectrum2_000948
Spectrum3_001373
Spectrum4_000367
Spectrum5_001074
SR-01000000284
SR-01000000284-2
ST51015129
Tachionin
Tolcasone
Tox21_110421
Tox21_110421_1
TR-004572
Trichlordiuride
Trichlormas
Trichlormetazid
Trichlormethiazid
trichlormethiazide
Trichlormethiazide (Achletin)
Trichlormethiazide (JP15/USP/INN)
Trichlormethiazide (JP17/USP/INN)
Trichlormethiazide [INN:JAN]
Trichlormethiazide W/ Reserpine
Trichlormethiazide, >=98%
Trichlormethiazide, United States Pharmacopeia (USP) Reference Standard
Trichlormethiazidum
Trichlormethiazidum [INN-Latin]
Trichloromethiadiazide
Trichloromethiazide
trichloromethiazide, 6
Triclordiuride
Triclormetiazida
Triclormetiazida [INN-Spanish]
Triclormetiazida[INN-Spanish]
Triclormetiazide
Triclormetiazide [DCIT]
Triclormetiazide [Italian]
Triflumen
Triflumen (TN)
WLN: T66 BSWM EM DHJ DYGG HG ISZW

US Patents and Regulatory Information for TRICHLOREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett TRICHLOREX trichlormethiazide TABLET;ORAL 083436-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett TRICHLOREX trichlormethiazide TABLET;ORAL 085630-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Farmers Insurance
Daiichi Sankyo
Julphar
AstraZeneca
Chinese Patent Office
McKinsey
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.